Sonoma Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

NOTE 7 - Property and Equipment

NOTE 7 - Property and Equipment

12 Months Ended

Mar. 31, 2012

Property, Plant and Equipment Disclosure [Text Block]

NOTE 7 — Property and Equipment

Property and equipment consists of the following (in thousands):

	March 31,
	2012			2011
Manufacturing, lab, and other equipment	$	2,666		$	2,375
Office equipment		334			333
Furniture and fixtures		55			53
Leasehold improvements		269			284
		3,324			3,045
Less: accumulated depreciation and amortization		(2,518	)		(2,243	)
	$	806		$	802

Depreciation and amortization expense amounted to $326,000 and $395,000 for the years ended March 31, 2012 and 2011, respectively.

During the year ended March 31, 2011, the Company incurred losses on the disposal of assets in the amount of $157,000. This amount was recorded within operating expenses in the accompanying consolidated statements of operations for the year ended March 31, 2011. During the year ended March 31, 2012, the Company did not incur losses related to the disposal of assets.

- Definition

The entire disclosure for long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software. This disclosure may include property plant and equipment accounting policies and methodology, a schedule of property, plant and equipment gross, additions, deletions, transfers and other changes, depreciation, depletion and amortization expense, net, accumulated depreciation, depletion and amortization expense and useful lives, income statement disclosures, assets held for sale and public utility disclosures.

+ References + Details